Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Omalizumab
(D05251)		1件: Omalizumab1件: Omalizumab (D05251) 💬 1件: FCER1A 💬 4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬7件: 46, 53, 65, 98, 162, 226, 299 💬
2Omalizumab (Xolair)
(D05251)		1件: Omalizumab1件: Omalizumab (D05251) 💬 1件: FCER1A 💬 4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬1件: 65 💬
3Recombinant humanized monoclonal antibody omalizumab to IgE
(D05251)		1件: Omalizumab1件: Omalizumab (D05251) 💬 1件: FCER1A 💬 4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬1件: 299 💬
4Rituximab combined with Omalizumab
(D05251)		2件: Omalizumab,
Rituximab		2件: Rituximab ,
Omalizumab (D05251) 💬 		2件: FCER1A,
MS4A1 💬 		5件: Asthma, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬1件: 162 💬